28 research outputs found

    Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium

    Get PDF
    Objective To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants of the MMR genes in the PLSD and IMRC cohorts, of which only the former included mandatory colonoscopy surveillance for all participants. Methods CRC incidences were calculated in an intervention group comprising a cohort of confirmed carriers of pathogenic or likely pathogenic variants in mismatch repair genes (path_MMR) followed prospectively by the Prospective Lynch Syndrome Database (PLSD). All had colonoscopy surveillance, with polypectomy when polyps were identified. Comparison was made with a retrospective cohort reported by the International Mismatch Repair Consortium (IMRC). This comprised confirmed and inferred path_MMR carriers who were first- or second-degree relatives of Lynch syndrome probands. Results In the PLSD, 8,153 subjects had follow-up colonoscopy surveillance for a total of 67,604 years and 578 carriers had CRC diagnosed. Average cumulative incidences of CRC in path_MLH1 carriers at 70 years of age were 52% in males and 41% in females; for path_MSH2 50% and 39%; for path_MSH6 13% and 17% and for path_PMS2 11% and 8%. In contrast, in the IMRC cohort, corresponding cumulative incidences were 40% and 27%; 34% and 23%; 16% and 8% and 7% and 6%. Comparing just the European carriers in the two series gave similar findings. Numbers in the PLSD series did not allow comparisons of carriers from other continents separately. Cumulative incidences at 25 years were < 1% in all retrospective groups. Conclusions Prospectively observed CRC incidences (PLSD) in path_MLH1 and path_MSH2 carriers undergoing colonoscopy surveillance and polypectomy were higher than in the retrospective (IMRC) series, and were not reduced in path_MSH6 carriers. These findings were the opposite to those expected. CRC point incidence before 50 years of age was reduced in path_PMS2 carriers subjected to colonoscopy, but not significantly so

    Impact of Adiponectin Overexpression on Allergic Airways Responses in Mice

    Get PDF
    Obesity is an important risk factor for asthma. Obese individuals have decreased circulating adiponectin, an adipose-derived hormone with anti-inflammatory properties. We hypothesized that transgenic overexpression of adiponectin would attenuate allergic airways inflammation and mucous hyperplasia in mice. To test this hypothesis, we used mice overexpressing adiponectin (Adipo Tg). Adipo Tg mice had marked increases in both serum adiponectin and bronchoalveolar lavage (BAL) fluid adiponectin. Both acute and chronic ovalbumin (OVA) sensitization and challenge protocols were used. In both protocols, OVA-induced increases in total BAL cells were attenuated in Adipo Tg versus WT mice. In the acute protocol, OVA-induced increases in several IL-13 dependent genes were attenuated in Adipo Tg versus WT mice, even though IL-13 per se was not affected. With chronic exposure, though OVA-induced increases in goblet cells numbers per millimeter of basement membrane were greater in Adipo Tg versus WT mice, mRNA abundance of mucous genes in lungs was not different. Also, adiponectin overexpression did not induce M2 polarization in alveolar macrophages. Our results indicate that adiponectin protects against allergen-induced inflammatory cell recruitment to the airspaces, but not development of goblet cell hyperplasia

    Real time PCR.

    No full text
    <p>Pulmonary mRNA expression of ki67 (A) and saa3 (B) in lungs of mice exposed to room air or O<sub>3</sub> (0.3 ppm ) for 72 h. Expression was normalized to 18 s and expressed relative to wildtype mice exposed to O<sub>3</sub>. *p<0.05 versus air exposed mice of the same genotype, #p<0.05 versus wildtype mice with the same exposure. Results are mean ± SEM of data from 4–7 air exposed mice and 6–10 ozone exposed mice.</p

    Cytokine and chemokine expression.

    No full text
    <p>BAL IL-6 (A), G-CSF (B), LIF (C), IL-5 (D), pulmonary IL-17A mRNA expression (E), and soluble TNFR1 (sTNFR1) (F) in mice exposed to room air or O<sub>3</sub> (0.3 ppm) for 72 hours. *p<0.05 versus air exposed mice of the same genotype, #p<0.05 versus wildtype mice with the same exposure, + p<0.05 versus T-cadherin deficient mice with the same exposure. Results are mean ± SEM of data from 3–5 air exposed mice and 3–7 ozone exposed mice for IL-6, G-CSF, LIF, and IL-5; 4–9 air exposed and 4–9 for ozone exposed mice for IL-17A mRNA; and 4–7 air exposed and 6–10 ozone exposed mice for sTNFR1;.</p
    corecore